Asper Biogene OÜ

Year	Period	Submitted	Status
2025	01.01.2025 – 31.12.2025	30.06.2026	Valid	PDF
2024	01.01.2024 – 31.12.2024	30.06.2025	Valid	PDF
2023	01.01.2023 – 31.12.2023	27.06.2024	Valid	PDF
2022	01.01.2022 – 31.12.2022	26.06.2023	Valid	PDF
2021	01.01.2021 – 31.12.2021	30.06.2022	Valid	PDF
2020	01.01.2020 – 31.12.2020	25.06.2021	Valid	PDF
2019	01.01.2019 – 31.12.2019	02.07.2020	Valid	PDF
2018	01.01.2018 – 31.12.2018	29.06.2019	Valid	PDF
2017	24.05.2017 – 31.12.2017	30.06.2018	Valid	PDF

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 20.10.2026.

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions1 Official announcements1 TTJA decisions–Real estate–.ee domains2 Licenses–Regulations14 Public transactions528 Grants1 State aid9 Public procurement12 Holdings in companies–Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q3	23 311 €	20 288 €	43 017 €−31,2%	11
2026 Q2	27 370 €	19 577 €	62 570 €+1,4%	11
2026 Q1	40 977 €	28 024 €	61 730 €+15,1%	11
Total 2026:	91 658 €	67 889 €	167 317 €
2025 Q4	32 395 €	25 565 €	53 643 €−13,6%	12
2025 Q3	31 812 €	24 010 €	62 090 €−14,2%	13
2025 Q2	33 329 €	24 406 €	72 390 €+44,5%	13
2025 Q1	26 123 €	23 024 €	50 100 €−30,9%	13
Total 2025:	123 659 €	97 005 €	238 223 €
2024 Q4	27 162 €	20 580 €	72 541 €+7,9%	13
2024 Q3	33 350 €	24 121 €	67 212 €−21,1%	13
2024 Q2	36 851 €	30 520 €	85 182 €+6,1%	13
2024 Q1	26 583 €	29 172 €	80 267 €−29,1%	13
Total 2024:	123 946 €	104 393 €	305 202 €
2023 Q4	38 350 €	24 729 €	113 169 €+93,0%	11
2023 Q3	29 034 €	24 126 €	58 625 €−41,3%	11
2023 Q2	37 958 €	25 547 €	99 903 €−10,0%	11
2023 Q1	49 657 €	26 425 €	110 961 €+115%	12
Total 2023:	154 999 €	100 827 €	382 658 €
2022 Q4	26 755 €	25 455 €	51 714 €+4,1%	13
2022 Q3	26 415 €	24 262 €	49 688 €−9,7%	13
2022 Q2	38 984 €	26 883 €	55 024 €−18,0%	13
2022 Q1	35 713 €	30 893 €	67 088 €−10,4%	14
Total 2022:	127 867 €	107 493 €	223 514 €
2021 Q4	34 535,05 €	29 915,18 €	74 855,41 €−38,2%	15
2021 Q3	37 133,50 €	34 527,35 €	121 202,71 €−1,3%	15
2021 Q2	28 551,33 €	27 991,17 €	122 842,16 €+10,3%	16
2021 Q1	37 299,33 €	36 184 €	111 404,96 €−2,2%	16
Total 2021:	137 519,21 €	128 617,70 €	430 305,24 €
2020 Q4	39 504,18 €	33 145,57 €	113 866,48 €+13,9%	17
2020 Q3	23 731,15 €	23 384,02 €	100 004,35 €−52,0%	17
2020 Q2	44 106,57 €	33 952,64 €	208 138,77 €+26,2%	18
2020 Q1	40 584 €	36 743 €	164 897 €+37,0%	18
Total 2020:	147 925,90 €	127 225,23 €	586 906,60 €
2019 Q4	36 328 €	34 243 €	120 356 €−18,8%	18
2019 Q3	37 588 €	31 580 €	148 288 €+18,6%	18
2019 Q2	32 861 €	30 486 €	124 982 €−43,1%	17
2019 Q1	32 833 €	30 561 €	219 816 €+60,8%	17
Total 2019:	139 610 €	126 870 €	613 442 €
2018 Q4	36 296 €	29 854 €	136 740 €+79,2%	17
2018 Q3	29 782 €	30 614 €	76 317 €−62,9%	20
2018 Q2	32 082 €	28 548 €	205 930 €+54,0%	20
2018 Q1	38 095 €	37 305 €	133 762 €−37,7%	20
Total 2018:	136 255 €	126 321 €	552 749 €
2017 Q4	54 392 €	35 548 €	214 802 €+169%	22
2017 Q3	18 021 €	11 577 €	79 789 €	22
2017 Q2	0 €	0 €	0 €	0
Total 2017:	72 413 €	47 125 €	294 591 €

Revenue by industry

	2023	2024	2025
Research and experimental development on natural and technical sciences		649 888 €	589 232 €
Research and development in biotechnology	825 111 €

Tax debts

No tax debt found

No tax debt as of 20.10.2026

Representatives

	Personal ID code
Hardi Tamm	37410XXXXXX	09.10.1974 (52)	Board member	08.06.2021	-

9 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Shareholders

	Personal ID code
OÜ Asper Biolab	11538286	30.09.2008 (18)	Shareholder	2 500 EUR	100,00%	Sole ownership	02.09.2023	-

9 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Other persons

	Personal ID code
Villem Aruoja	36905XXXXXX	13.05.1969 (57)	Founder	23.05.2017	-

9 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Katrin Tamm	47405XXXXXX	11.05.1974 (52)	Indirect holding	17.06.2022	-
Hardi Tamm	37410XXXXXX	09.10.1974 (52)	Indirect holding	25.06.2021	-

9 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

1 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

2026 Q3

Turnover

Amount: 43 017 €
Monthly average: 14 339 €
Per employee: 1 304 €
Equity ratio: 573,56%

Labour taxes

Turnover ratio: 47,16%
Tax ratio: 87,03%
Monthly average: 6 763 €
Per employee: 615 €

State taxes

Monthly average: 7 770 €
Turnover ratio: 54,19%

Estimated salary

Gross salary: 1 240 €
Net salary: 1 087 €

Aggregate data

Last 5 yrsAll

	2025	2024	2023	2022	2021	2020	2019
Current assets	121 222 €−0,5%	121 827 €−37,9%	196 090 €−16,4%	234 590 €+97,7%	118 675 €−11,7%	134 445 €−13,2%	154 865 €
Non-current assets	105 781 €−60,8%	270 129 €−8,6%	295 524 €−17,9%	360 098 €+18,5%	303 812 €+38,9%	218 662 €+29,4%	168 952 €
Total assets	227 003 €−42,1%	391 956 €−20,3%	491 614 €−17,3%	594 688 €+40,8%	422 487 €+19,6%	353 107 €+9,0%	323 817 €
Short-term liabilities	95 078 €+5,4%	90 228 €−27,0%	123 518 €−48,8%	241 220 €+18,8%	203 113 €+20,0%	169 198 €+26,9%	133 344 €
Long-term liabilities	19 278 €−9,4%	21 278 €	21 278 €	21 278 €−50,5%	42 995 €	42 995 €−52,3%	90 200 €
Total liabilities	114 356 €+2,6%	111 506 €−23,0%	144 796 €−44,8%	262 498 €+6,7%	246 108 €+16,0%	212 193 €−5,1%	223 544 €
Share or stock capital	-	-	-	-	-	-	-
Retained earnings	277 700 €−19,3%	344 068 €+4,4%	329 440 €+89,7%	173 629 €+25,7%	138 164 €+41,7%	97 523 €+16,5%	83 723 €
Net profit	-167 803 €−153%	-66 368 €−554%	14 628 €−90,6%	155 811 €+339%	35 465 €−12,7%	40 641 €+189%	14 050 €
Equity	112 647 €−59,8%	280 450 €−19,1%	346 818 €+4,4%	332 190 €+88,3%	176 379 €+25,2%	140 914 €+40,5%	100 273 €
Turnover	589 232 €−9,3%	649 888 €−21,2%	825 111 €+5,5%	782 438 €+20,0%	651 969 €−17,1%	786 521 €+15,3%	681 879 €
Profit margin	-28,5%	-10,2%	1,8%	19,9%	5,4%	5,2%	2,1%

Financial ratios

	2022	2021
Profit and cash flow
EBITDA	236 032 €	67 368 €
Liquidity
Current ratio	1,0	0,6
Quick ratio	1,0	0,6
Cash ratio	0,2	0,2
Efficiency
Days sales outstanding (dso)	52,3	33,8
Asset turnover	1,5	1,7
Structure
Debt ratio	0,4	0,6
Profitability
Operating margin	24,0%	6,6%
Net profit margin	19,9%	5,4%
Return on assets (roa)	30,6%	9,1%
Return on equity (roe)	46,9%	20,1%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations


Ä 50057920 / 12	18.11.2024	Entry – Amendment entry	-	Entered into force18.11.2024
Ä 50057920 / 11	02.09.2023	Entry – Amendment entry	-	Entered into force02.09.2023
Ä 50057920 / 10	30.06.2023	Entry – Amendment entry	-	Entered into force30.06.2023
Ä 50057920 / 9	08.06.2021	Entry – Amendment entry	-	Entered into force08.06.2021
Ä 50057920 / 8	18.02.2020	Entry – Amendment entry	-	Entered into force18.02.2020

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions


4-25-326/35	Kohtu I astme menetlus	Court judgment	Other misdemeanours	Marek Vahing	ECLI:EE:TMK:2025:4.25.326.12147	26.06.2025	Open

Official announcements


Notice of issuance of a licence to handle infectious material	22.09.2017	PDF

Public transactions


15.09.2026	Kuressaare Haigla Sihtasutus	986,78 €Received	OPERATING EXPENSESGeneral hospital services
10.09.2026	Sihtasutus Pärnu Haigla	2 093,71 €Received	OPERATING EXPENSESGeneral hospital services
10.09.2026	Sihtasutus Pärnu Haigla	1 632,65 €Received	OPERATING EXPENSESGeneral hospital services
31.08.2026	Aktsiaselts Ida-Tallinna Keskhaigla	31 010,79 €Received	OPERATING EXPENSESGeneral hospital services
14.08.2026	Sihtasutus Tallinna Lastehaigla	3 289,30 €Received	OPERATING EXPENSESGeneral hospital services

Funded projects


Farmakogeneetilise testi prototüüb arendus2014-2020.4.04.20-1332	Ettevõtja arenguplaani toetusmeede ettevõtete arendus- ja eksporditegevustele kaasaaitamiseks ning juhtimisvõimekuse tõstmiseksERDF · Ettevõtluse ja Innovatsiooni Sihtasutus	06.07.2020 – 06.01.20212014-2020	35 000 €support 70,0%	34 985 €	Completed

State aid


30.09.2026	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 241718	T&A VTA › T&A VTAGrant	4 996,46 €	241718/2600413
18.03.2026	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 241718	T&A VTA › T&A VTAGrant	8 036,03 €	241718/2600107
08.10.2025	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 241718	T&A VTA › T&A VTAGrant	6 203,16 €	241718/2500467
11.04.2025	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 241718	T&A VTA › T&A VTAGrant	2 220,96 €	241718/2500178
13.03.2024	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 231472	EK grupierandi määrus 651/2014 VKEdele antav abi (artiklid 17 -20) › VKEdele nõustamiseks antav abi (artikkel 18)Grant	4 446 €	231472/2400005

Public procurement contracts


10.07.2026End 09.07.2030	Reference number 309282 · Raamleping	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	371 344,15 €	Concluded
18.03.2026End 17.03.2027	Reference number 300341 · Labori- ja patoloogiateenuste tellimise raamleping nr 3 2/355 1 (Asper Biogene)	Aktsiaselts Lääne-Tallinna KeskhaiglaContracting authority	1 000 000 €	Concluded
21.11.2024End 20.11.2025	Reference number 268870 · II periood 21.11.2024 – 20.11.2025	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	387 381,79 €	Completed
21.11.2023End 20.11.2024	Reference number 268870 · I periood 21.11.2023 – 20.11.2024	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	482 305,57 €	Completed
21.11.2023End 20.11.2026	Reference number 268870 · Raamleping_Asper Biogene	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	584 989,21 €	Concluded

.ee domains


asperbio.ee	Active	15.09.2021	16.09.2027
asper.ee	Active	15.09.2021	16.09.2027

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.